4/12/2013

Merck & Co. granted Hawaii Biotech rights to a family of patents to West Nile virus vaccine technology and nonexclusive license to related technologies. The deal will allow Hawaii Biotech to continue work on its West Nile virus vaccine, said CEO Elliot Parks.

Related Summaries